Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Mol Cancer Res. 2019 May 28;17(9):1920–1930. doi: 10.1158/1541-7786.MCR-18-1291

Table 1.

RNA trans-splicing factor candidate screen with siRNA for CPEB2A/B Protein Ratio

Protein CPEB2A/B ratio
No Treatment 7.40
Non-targeting control 6.96
SRSF3 19.0
hnRNP H1 9.78
hnRNP F 7.06
hnRNP H1/F 3.58